Textual Modalities for: Biological products except diagnostic
Records: Showing 20 of 483 total records
Page: 13 of 25
| Code | Title | Description | Source | Word Counts | URL |
|---|---|---|---|---|---|
| 283699.0 | FDA Releases Two Discussion Papers on AI and ML | AI and ML in the Development of Drug and Biological Products. The discussion paper is a collaboratio... | Total words: 938 | biological: 2 | products: 4 | View | |
| 283699.0 | Next-Generation Sequencing Technology: Current Trends and Advancements | This has been widely used as a resource for estimating allele frequency in rare diseases, disease ge... | Total words: 14,355 | biological: 13 | products: 1 | diagnostic: 5 | View | |
| 283699.0 | Guidance for Industry and FDA Staff:PDF | marketed drugs/biological products (i.e., without a specified drug or biological product) generally ... | Total words: 10,469 | biological: 26 | products: 73 | View | |
| 283699.0 | Types of intervention and their development - Field Trials of Health ... | 3. Evolution of new intervention products and sequence of study phases. Many intervention products, ... | Total words: 6,094 | biological: 2 | products: 8 | except: 1 | diagnostic: 9 | View | |
| 283699.0 | 9530 Federal Register /Vol. 84, No. 51/Friday, March 15, 2019 ... - GovInfoPDF | Animal Sources (Except for In Vitro Diagnostic Devices).’’ Received comments will be placed in t... | Total words: 1,701 | biological: 1 | products: 2 | except: 10 | diagnostic: 8 | View | |
| 283699.0 | eCFR :: 21 CFR Part 864 -- Hematology and Pathology Devices | § 864.3 Effective dates of requirement for premarket approval. A device included in this part that ... | Total words: 17,960 | biological: 9 | products: 22 | except: 4 | diagnostic: 46 | View | |
| 283699.0 | Requirements on Content and Format of Labeling for Human Prescription ... | The agency is, therefore, limiting identification of the initial date of U.S. approval to new molecu... | Total words: 72,138 | biological: 48 | products: 370 | except: 29 | diagnostic: 1 | View | |
| 283699.0 | Review and Approval | FDA | All FDA-approved biological products (biologics), including biosimilars and interchangeable biosimil... | Total words: 1,150 | biological: 11 | products: 16 | View | |
| 283699.0 | Biological and cognitive theories explaining panic disorder: A ... | Keywords: panic disorder, etiology, biological theories, psychological theories, narrative review. I... | Total words: 10,589 | biological: 28 | diagnostic: 2 | View | |
| 283699.0 | Virome Characterization in Commercial Bovine Serum Batches-A ... | Bovine serum has been widely used as a universal supplement in culture media and other applications,... | Total words: 1,847 | biological: 7 | products: 6 | diagnostic: 1 | View | |
| 283699.0 | Tissue Engineering and Regenerative Medicine: Achievements, Future, and ... | (A) An interwoven aligned conductive nanofiber yarn/hydrogel hybrid scaffolds for mimicking the nati... | Total words: 35,323 | biological: 11 | products: 12 | except: 3 | View | |
| 283699.0 | Reporting Amount of Listed Drugs and Biological Products Under Section ... | of listed drugs, except for biological products or categories thereof exempted by an order under sec... | Total words: 9,602 | biological: 28 | products: 54 | except: 6 | View | |
| 283699.0 | Definition of the Term “Biological Product” - Federal Register | Although the majority of therapeutic biological products have been licensed under section 351 of the... | Total words: 7,912 | biological: 41 | products: 22 | except: 10 | View | |
| 283699.0 | Evidence-based clinical practice guidelines for inflammatory bowel ... | Diagnostic approach to Crohn's disease. BQ 5. What are the diagnostic criteria for IBD? Statement. A... | Total words: 26,168 | biological: 5 | products: 1 | except: 1 | diagnostic: 26 | View | |
| 283699.0 | Depression: Biological markers and treatment - PubMed | The second part of the paper includes the most recent findings about available medical treatment of ... | Total words: 1,382 | biological: 4 | diagnostic: 1 | View | |
| 283699.0 | Current Bioprocess Technology, Products, and Opportunities | 4.1.2. Inclusion Bodies. High levels of protein synthesis have been obtained with several intracellu... | Total words: 8,340 | biological: 16 | products: 51 | except: 4 | diagnostic: 2 | View | |
| 283699.0 | Guidance for Industry - U.S. Food and Drug Administration | signed into law on December 13, 2016, is intended to 19 accelerate medical product development and b... | Total words: 3,980 | biological: 6 | products: 8 | except: 1 | View | |
| 283699.0 | Dosage and Administration Section of Labeling for Human Prescription ... | biological products licensed under section 351 of the Public Health Service Act (PHS Act) (42 U.S.C.... | Total words: 12,909 | biological: 26 | products: 52 | except: 3 | diagnostic: 1 | View | |
| 283699.0 | Relapsing polychondritis: A 2016 update on clinical features ... | Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biolog... | Total words: 1,334 | biological: 3 | products: 2 | diagnostic: 2 | View | |
| 283699.0 | Medical Devices: Research and Development for Rare Diseases | For rare diseases, efforts to accelerate research and product development clearly focus on drugs and... | Total words: 13,878 | biological: 7 | products: 35 | except: 2 | diagnostic: 32 | View |
Page 13 of 25 (483 records)